High-Quality Phase I-IV Clinical Trial Conduct
/PRNewswire/ -- Apex Innovative Sciences ("Apex" or the "Company"), a leading provider of clinical development and trial site services, is pleased to announce...
Stay updated with breaking news from Innovative Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Apex Innovative Sciences ("Apex" or the "Company"), a leading provider of clinical development and trial site services, is pleased to announce...
Researchers have come up with a new technology to deliver augmented and virtual reality glasses that don’t look like “bug eyes.” “Image” is everything in the $20 billion market for AR/VR glasses. Consumers are looking for glasses that are compact and easy to wear, delivering high-quality imagery with socially acceptable optics. In a new paper in Science Advances, researchers describe imprinting freeform optics with a nanophotonic optical element called “a metasurface.” The metasurface is a veritable forest of tiny, silver, nanoscale structures on a thin metallic film that confo...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a ... BioXcel TherapeuticsFebruary 12, 2021 GMT NEW HAVEN, Conn., Feb. 12, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that the Company will host a virtual Key Opinion Leader (“K...